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Abstract
Background: Coxiella burnetii is the etiological agent of Q fever. The clinical diagnosis of Q fever is mainly based
on several serological tests. These tests all need Coxiella organisms which are difficult and hazardous to culture
and purify.
Results: An immunoproteomic study of C. burnetii Xinqiao strain isolated in China was conducted with the sera
from experimentally infected BALB/c mice and Q fever patients. Twenty of whole proteins of Xinqiao recognized
by the infection sera were identified by mass spectrometry. Nineteen of the 20 proteins were successfully
expressed in Escherichia coli and used to fabricate a microarray which was probed with Q fever patient sera. As a
result, GroEL, YbgF, RplL, Mip, OmpH, Com1, and Dnak were recognized as major seroreactive antigens. The major
seroreactive proteins were fabricated in a small microarray and further analyzed with the sera of patients with
rickettsial spotted fever, Legionella pneumonia or streptococcal pneumonia. In this analysis, these proteins showed
fewer cross-reactions with the tested sera.
Conclusions: Our results demonstrate that these 7 Coxiella proteins gave a modest sensitivity and specificity for
recognizing of Q fever patient sera, suggesting that they are potential serodiagnostic markers for Q fever.
Background
Coxiella burnetii is a Gram-negative bacterium that
causes the worldwide zoonotic disease “Q fever”.I n
humans, the disease generally arises from inhalation of
the aerosolized Coxiella organisms produced by infected
livestock. Acute Q fever usually presents as an influ-
enza-like illness with various degrees of pneumonia [1],
which may be self limiting or effectively treated with
antibiotics. However, chronic Q fever is typically mani-
fested as endocarditis, osteomyelitis or infected aortic
aneurysms [1,2], and is difficult to treat.
The clinical diagnosis of Q fever is mainly based on
serological tests including indirect immunofluorescence
assay (IFA), enzyme-linked immunosorbent assay
(ELISA) and complement fixation (CF) [1-3]. These
tests have several limitations: large sample/reagent
volume requirements, complex protocols, and differing
sensitivities and specificities [4]. Furthermore, they all
need purified Coxiella organisms which are difficult and
hazardous to culture and purify [3]. Identifying novel
seroreactive proteins could be a step towards the devel-
opment of a fast, specific and safe molecular diagnostic
assay instead of traditional serological tests. Immuno-
proteomic methods have been successfully applied in
identifying seroreactive proteins of other pathogens
[5,6]. Several immunoproteomic studies on C. burnetii
have also been reported with various seroreactive pro-
teins identified [7-12].
In this study, the proteins of C. burnetii Xinqiao, a phase
I strain isolated in China [13], were analyzed with sera
from experimentally infected BALB/c mice and Q fever
patients using immunoproteomic analysis.
Results
C. burnetii infection in BALB/c mice
Five days post infection (pi), mice showed clinical symp-
toms: gathered together, reduced movement, ruffled fur,
but no deaths occurred. The DNA samples extracted
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detected by qPCR. High levels of Coxiella DNA were
found in liver and spleen tissues (Figure 1) and the high-
est level was found in tissues obtained on day 7 pi. The
Coxiella load in spleen tissues was significantly higher
than that in liver or lung tissues and significantly
decreased by day 14 pi (Figure 1).
Seroreactive proteins recognized with specific sera
The lysates of purified Coxiella organisms was separated
by 2D-PAGE and a proteome map of C. burnetii was
obtained (Figure 2). More than 500 distinct protein spots
with isoelectric points (pIs) ranging from 3 to 10 and
molecular mass ranging from 14 to 70 kDa were visua-
lized by Coomassie blue stain. Following the immunoblot
assay, 0, 4, 9, and 14 of the Coxiella proteins were recog-
nized by the mice sera obtained at 7, 14, 21, and 28 days
pi, respectively (Figure 3). Among these recognized
proteins, 3 proteins, Chaperonin GroEL (GroEL), pepti-
dyl-prolyl cis-trans isomerase (Mip) and putative outer
membrane chaperone protein (OmpH), were strongly
recognized by sera obtained at days 14, 21, and 28 days
pi, and the 27 kDa outer membrane protein (Com1) was
recognized by sera obtained at day 14 and strongly recog-
nized by sera obtained on days 21 and 28 pi (Figure 3,
Table 1). In addition, 15 of the Coxiella proteins were
recognized by sera from two patients during the acute
phase of Q fever. However, 6 of the 15 proteins, including
70 kDa chaperone protein (DnaK), LSU ribosomal pro-
tein L12P (RplL), 3-oxoacyl-[acyl-carrier-protein]
synthase 2 (FabF), S-adenosylmethionine synthetase
(MetK), acute disease antigen A (AdaA), glutamine
synthetase (glnA), were not recognized by the mouse sera
(Figure 3, Table 1).
Serological analysis of the recombinant seroreactive
proteins with Q fever patient sera
Twenty genes encoding the seroreactive proteins were
amplified (Additional file 1: Table S1) and cloned into the
pET32a/pQE30 plasmid. Except for the rpsB-recombinant
plasmid, the rest were successfully expressed in E. coli
cells. The 19 recombinant proteins were purified by
Ni-NTA agarose and analyzed by sodium dodecylsulfate
polyacrylamide gel electrophoresis (SDS-PAGE). Then
they were used to fabricate a protein microarray.
The protein microarray was probed with 56 sera from
patients with acute Q fever and 25 sera from healthy per-
sons (normal sera). The average FI value of the proteins
probed with acute early, late or convalescent Q fever
patient sera were significantly higher compared with that
probed with the normal sera (P < 0.05) The average FI
values of the proteins probed with acute late Q fever
patient sera were significantly higher than acute early or
convalescent Q fever patient sera (P < 0.05). The protein
was considered to be seroreactive if its average FI probed
with the patient sera were higher than the mean FI plus
twice the standard deviation probed with normal sera
(Additional file 2: Table S2). Seven recombinant proteins
(GroEL, YbgF, RplL, Mip, Com1, OmpH, and Dnak) were
selected as major seroreactive proteins with sensitivities
that ranged from 48% to 88% when probed with acute late
Q fever sera. The recombinant GroEL gave the highest
sensitivity at 88% (Table 2).
Specificity analysis of the major seroreactive proteins
A small microarray fabricated with GroEL, YbgF, RplL,
Mip, Com1, OmpH, and Dnak was probed with rickett-
sial spotted fever, Legionella pneumonia or streptococcal
pneumonia patient sera. The average FI value of each
protein probed with acute late Q fever patient sera were
significantly higher compared with that probed with the
sera from the other three groups of patients (P < 0.05). A
reaction was considered positive if the average FI of one
protein probed with one of the tested sera were higher
than the mean FI plus 2 times the standard deviation
probed with the sera of healthy person sera (Additional
file 3: Table S3). As a result, YbgF and DnaK displayed
no reaction with any of the tested sera, and Com1 and
Mip cross-reacted with one or two of the rickettsial
spotted fever patient sera (Table 3). OmpH cross-reacted
with one of the Legionella pneumonia or streptococcal
pneumonia patient sera; GroEL cross-reacted with one of
the Legionella pneumonia and two of the rickettsial
spotted fever patient sera; RplL cross-reacted with two of
the Legionella pneumonia and three of the streptococcal
pneumonia patient sera (Table 3).
Figure 1 The detection of C. burnetii load in BALB/c mice post-
infection. Coxiella burnetii load in mice organs experimentally
infected and tested by real-time quantitative PCR on 0, 7, 14, 21
and 28 days pi. In quantitative PCR analysis, the copy number per
mouse was obtained with 1% of the DNA sample extracted from 10
mg spleen tissue. Coxiella DNA copies were determined in groups
of eight mouse samples by quantitative PCR. The results are
expressed as the average copy number of eight samples on a lg
scale and error bars indicate the standard deviation.
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C. burnetii Xinqiao was isolated from ticks in China and
its phase I phenotype was demonstrated in a previous
study [13]. In this current study, C. burnetii Xinqiao
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C. burnetii was found in the spleens and livers of the
infected mice by qPCR analysis. The Coxiella load in
spleens was significantly higher compared with that in
the other organs of the infected mice, indicating that
the mouse spleen is the most important organ for
C. burnetii propagation and its Coxiella load may reflect
the severity of C. burnetii infection. The highest level of
Coxiella in spleens of the infected mice was found on day
7 pi and then gradually decreased, indicating that the
infected mice recovered gradually from the severe infec-
tion. These results also indicate that the combination of
the sublethal challenge mouse model and the qPCR assay
may be a useful and sensitive way to evaluate severity of
the infection caused by different C. burnetii strains and
evaluate efficiency of drugs or vaccines against this
pathogen.
In order to identify the seroreactive proteins of C. burne-
tii Xinqiao, the whole cell lysates of the organism was sepa-
rated by 2-D electrophoresis. Immunoblot analysis using
the sera of mice obtained at days 14, 21, and 28 pi, indenti-
fied 4, 9, and 14 of the separated proteins, respectively.
This indicated that the specific immune responses to
C. burnetii developed progressively in the infected mice
with additional antigens of C. burentii recognized as the
immune response grew further. In addition, 15 of the pro-
teins were recognized by sera from two patients with acute
Q fever. Among these seroreactive proteins, 9 proteins
were recognized by both the mouse and human sera, indi-
cating that these proteins are able to elicit similar humoral
immune responses to C. burnetii infection in both species.
A total of 20 seroreactive proteins were recognized by
the positive mouse or human sera by mass spectra of
MALDI-TOF-MS. GroEL, a conserved heat shock protein
(HspB) [14], has been reported as a major immunodomi-
nant antigen of C. burnetii [15]. YbgF, a tol-pal system
protein that involved in bacterial outer membrane stability
[16], was found in both phases of C. burnetii [12]. GroEL
and YbgF were both recognized by the sera of C. burnetii-
infected mice and the Q fever patient sera in this study
and have been previously documented as seroreactive anti-
gens using a proteomic approach [7-9]. While Com1, Mip,
and OmpH were recognized by the sera of C. burnetii-
infected mice but were not recognized by Q fever patient
Figure 2 2D gel proteome reference map of C. burnetii Xinqiao strain. Isoelectric focusing was performed with a total protein extract of C.
burnetii using a 17 cm pH 3 to 10 nonlinear Immobiline DryStrip, followed by SDS-PAGE on a 12.5% Bis-tris gel and stained by modified
Coomassie brilliant blue. The numbers refer to the protein identified as shown in Table 1.
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and human sera were from different infection stages or
there were differences in humoral immune responses to
C. burnetii infection between mice and humans.
Com1 was first identified as an outer membrane-
associated seroreactive protein of C. burnetii by Hendrix
and colleagues [17]. Mip is a cell-surface associated pepti-
dylprolyl-isomerase related to macrophage infectivity
potentiator protein [18] and plays a role in enhancing
clearance of bacteria from spleens of infected mice [19].
OmpH is a putative outer membrane chaperone protein
required for efficient release of translocated proteins from
the plasma membrane [20]. The 3 proteins had also been
recognized as immunodominant antigens in other studies
[7,9,19,21,22]. DnaK, a surface-associated protein playing a
role in assisting with folding of nascent polypeptide chains
[23], and RplL, a ribosomal protein involved in translation,
were previously recognized as seroreactive [9,19]. In this
study, DnaK and RplL were most seroreactive when
probed with the sera of patients with acute Q fever but
were nonreactive when probed with the sera of C. burne-
tii-infected mice. Additionally, another 13 seroreactive
proteins identified in this study were housekeeping
enzymes, including FbaA, AtpD, and Tuf2 which are
involved in metabolism and biosynthesis. Eight of these
proteins were previously identified as seroreactive antigens
Figure 3 Immunoblot analysis of the separated proteins of C. burnetii Xinqiao strain. The separated proteins of C. burnetii Xinqiao were
probed with pooled mice sera obtained at 7(A), 14(B), 21(C) and 28(D) days pi as well as two late acute Q fever patient sera (E and F),
respectively. The identified antigens are denoted with circles and listed in Table 1.
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Page 4 of 10Table 1 Identification of the seroreactive proteins of C. burnetii by MALDI-TOF-MS and ESI-MS/MS
spot
no
Identification Gene
name
Locus tag NCBI no. Nominal
mass
Calculated
pI value
Identify
method
Score Expect
value
Queries
matched
%Sequence
coverage
Mice sera
(-days-p.i.)
Human
sera(A,B)
1 Chaperone protein dnaK CBU_1290 gi|
29654590
70826 5.14 MALDI-TOF 176 6.80E-12 21 38% - A,B
2 Chaperonin GroEL groEL CBU_1718 gi|
161830449
58375 5.14 MALDI-TOF 200 2.70E-14 24 52% 14,21,28 A,B
3 Trigger factor tig CBU_0737
COXBURSA
gi|
29654071
50215 5.3 MALDI-TOF 223 1.40E-16 32 67% 28 A,B
4 F0F1 ATP synthase subunit
beta
atpD 331_A2148 gi|
161830152
50490 5.01 MALDI-TOF 240 2.70E-18 26 54% 21,28 A,B
5 Dihydrolipoyllysine-residue
succinyltransferase
sucB CBU_1398 gi|
29654691
45908 5.54 MALDI-TOF 100 0.00027 16 34% 21,28 A
6 Fructose-1,6-bisphosphate
aldolase
fbaA CBU_1778 gi|
29655066
39793 5.41 MALDI-TOF 190 2.70E-13 16 48% 21,28 A,B
7 S-adenosylmethionine
Synthetase
metK CBU_2030 gi|
29655311
43150 5.55 MALDI-TOF 153 1.40E-09 20 50% - A,B
8 3-oxoacyl-[acyl-carrier-protein]
synthase 2
fabF CBU_0497 gi|
29653839
44275 5.49 MALDI-TOF 160 2.70E-10 20 58% - A
9 Elongation factor Tu tuf2 CBU_0236 gi|
29653588
43613 5.32 MALDI-TOF 285 8.60E-23 29 76% 28 A,B
10 Glutamine synthetase glnA CBU_0503 gi|
29653845
39876 5.33 MALDI-TOF 122 1.7e-06 15 44% - A
11 Malate dehydrogenase mdh CBU_1241 gi|
29654544
35732 5.07 MALDI-TOF 136 6.80E-08 19 50% 21,28 A
12 34 kDa outer membrane
protein
ybgF - gi|
30025849
33641 5.67 MALDI-TOF 92 0.0019 8 28% 21,28 A
13 (2R)-phospho-3-sulfolactate
synthase
comA CBU_1954 gi|
29655237
33383 5.38 MALDI-TOF 146 6.80E-09 16 52% 28 A
14 Inorganic diphosphatase ppa CBU_0628 gi|
29653966
19642 5.2 ESI-MS/MS 323 2.1e-26 7 36% 28 -
15 LSU ribosomal protein L12P
(L7/L12)
rplL CBU_0229
COXBURSA
gi|
29653581
13240 4.71 ESI-MS/MS 210 4.2e-15 6 48% - A,B
16 30S ribosomal protein S2 rpsB 331_A1545 gi|
161831161
35410 8.88 MALDI-TOF 100 0.00027 15 48% 28 -
17 Peptidyl-prolyl cis-trans
isomerase Mip
mip CBU_0630 gi|
29653968
25501 9.8 MALDI-TOF 133 6.10E-07 9 57% 14,21,28 -
18 27 kDa outer membrane
protein
com1 - gi|
11935138
26739 9.23 MALDI-TOF 95 0.00078 7 42% 14,21,28 -
19 Acute disease antigen A adaA CBU_0952 gi|
29654269
25935 8.67 MALDI-TOF 110 2.70E-05 15 38% - B
20 Putative outer membrane Skp ompH CBU_0612 gi|
29653950
18812 9.71 ESI-MS/MS 429 4.3e-37 5 28% 14,21,28 -
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0[7-9,21,24]. This indicated that metabolic enzymes
released from C. burnetii organisms were exposed to the
host immune system and induced a specific antibodies
response.
Nineteen of the 20 seroreactive proteins identified in
this immunoproteomics study were successfully
expressed in E. coli cells and the resultant recombinant
proteins were used to fabricate a protein microarray. To
evaluate their serodiagnostic potential, the protein micro-
array was probed with Q fever patient sera. As a result, 7
of the 19 proteins (GroEL, YbgF, RplL, Mip, Com1,
OmpH, and Dnak) gave a modest sensitivity of more
than 48% when probed with acute late Q fever patient
sera. We noted that inconsistency existed between
immunoproteomic and microarray data: the reaction of
Com1 was stronger than that of Mip, OmpH or YgbF in
immunoblot assay, whereas FI value of Mip, OmpH or
YgbF was higher than that of Com1 in microarray assay
with Q fever sera. The inconsistency might be caused by
the fact that the Q fever sera recognized linear epitopes
of Coxiella proteins in immunoblot assay whereas they
recognized conformational epitopes of recombinant pro-
teins in protein microarray assay.
Our results also showed that the average FI value of the
7 major seroreactive proteins probed with acute late sera
were significantly higher than those probed with acute
early or normal sera, which is generally in accordance with
IgG titers determined in IFA. This result firmly suggests
that the 7 major seroreactive proteins are immunodomi-
nant antigens of C. burnetii and they have capability to
evoke strong humoral immune responses in C. burnetii
infection. However, compared to IFA, the lower sensitivity
of some individual proteins in microarray assay with Q
fever patient sera, especially sera in acute early stage, was
observed, which might be due to the fact that there were
remarkable variation in immune recognition patterns for
Q fever and differences between the two assays in calculat-
ing positive values. When the seroreactive proteins were
analyzed in combination, 98% of antibody responders to
one or more of the 7 major seroreactive proteins could be
found among the Q fever patients. The remarkable varia-
tion in immune recognition patterns for Q fever requires
Table 2 Major seroreactive proteins of C. burnetii on microarray probed with Q fever patient sera
Fluorescence intensity Sensitivity
a
Protein Normal
(n = 25)
Acute early
(n = 25)
Acute late
(n = 25)
Convalescent
(n = 6)
Acute early Acute late Convalescent
GroEL 114 ± 84 1548 ± 1996 3915 ± 3462 642 ± 382 84% 88% 83%
YbgF 104 ± 83 752 ± 1308 1517 ± 1946 1176 ± 1061 44% 72% 67%
RplL 85 ± 88 277 ± 396 949 ± 1174 185 ± 119 20% 68% 17%
Mip 137 ± 78 324 ± 233 611 ± 669 237 ± 157 44% 60% 17%
Com1 70 ± 84 120 ± 326 461 ± 525 253 ± 176 12% 52% 50%
OmpH 141 ± 95 210 ± 195 676 ± 1192 398 ± 540 20% 48% 17%
DnaK 95 ± 91 143 ± 122 371 ± 480 165 ± 105 16% 48% 17%
aSensitivity was calculated as the percentage (the number of microarray-positive sera divided by the number of sera of patients with Q fever)
Table 3 Specificity analysis of the major seroreactive proteins of C. burnetii
Average FI value of group sera (positive No/serum No)
Protein Q fever Rickettsial spotted fever Legionella pneumophila Streptococcal pneumonia Normal
GroEL 980 ± 1020 279 ± 60 253 ± 72 218 ± 72 207 ± 63
(10/10) (2/10) (1/10) (0/10) (0/10)
YbgF 838 ± 442 274 ± 51 196 ± 76 197 ± 83 144 ± 111
(10/10) (0/10) (0/10) (0/10) (0/10)
RplL 823 ± 1404 211 ± 82 251 ± 115 292 ± 188 200 ± 81
(10/10) (0/10) (2/10) (3/10) (1/10)
Mip 361 ± 103 291 ± 31 230 ± 45 218 ± 47 227 ± 45
(10/10) (2/10) (0/10) (0/10) (0/10)
Com1 895 ± 1145 307 ± 105 250 ± 77 226 ± 77 187 ± 105
(10/10) (1/10) (0/10) (0/10) (0/10)
OmpH 648 ± 698 240 ± 54 217 ± 102 194 ± 142 147 ± 107
(10/10) (0/10) (1/10) (1/10) (0/10)
DnaK 310 ± 42 226 ± 64 207 ± 66 187 ± 63 226 ± 51
(10/10) (0/10) (0/10) (0/10) (0/10)
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responses and thus achieve the highest possible test
sensitivity.
YbgF, RplL, Mip, Com1, and OmpH were considered
as potential antigens for diagnosis of Q fever by other
investigators using in vitro transcription and translation
(IVTT)-based microarray of C. burnetii Nine Mile strain,
indicated that Xinqiao strain isolated in China shares
these major seroreactive antigens with Nine Mile strain
[19,21]. Two heat shock proteins GroEL and Dnak were
also recognized as major seroreactive antigens in this
study. The positive frequencies of GroEL probed with
acute early and acute late, and convalescent Q fever
patient sera were 84%, 88%, and 83%, respectively, higher
than the other major seroreactive proteins, suggesting
that GroEL is an excellent molecular marker for Q fever.
Additionally, the positive frequencies of YbgF with these
Q fever patient sera were 44%, 62%, and 77%, lower than
GroEL but higher than the other 5 major seroreactive
proteins, indicating that it is a better protein antigen for
Q fever diagnosis.
Rickettsial spotted fever caused by tick-borne infection
may share similar clinical feature with Q fever. Legionella
pneumonia is caused by Legionella pneumophila which is
the bacterium closely related to C. burnetii with genomic
homology and similar clinical presentations. Pneumonia
is the major clinical presentation of acute Q fever and
most bacterial pneumonia is caused by S. pneumoniae.
These bacterial infections must be distinguished from Q
fever using serological or molecular tests. Therefore, the
7 Coxiella proteins were used to fabricate a small micro-
array for further analysis of specificity with the sera of
patients with other infectious diseases. The average FI
value of each protein probed with acute late Q fever
patient sera was significantly higher than that probed
with the sera of patients with one of the three other
infectious diseases, which indicated that the major seror-
eactive proteins of Coxiella can be distinguished from
other bacteria in general. YbgF and DnaK displayed no
cross-reaction with any of the tested sera, and Com1,
Mip, OmpH and GroEL cross-reacted with one or two of
the sera of patients with rickettsial spotted fever, Legio-
nella pneumonia or bacterial pneumonia. RplL cross-
reacted with two of the Legionella pneumonia patient
sera and three of the streptococcal pneumonia patient
sera. In this analysis, these Coxiella proteins gave a mod-
est specificity for recognizing of Q fever patient sera,
suggesting that they are potential serodiagnostic markers
for Q fever.
Notably, GroEL had the highest sensitivity and modest
specificity for recognizing of Q fever, which may be the
most important antigen used for the diagnosis of Q fever.
The antigen combination, GroEL, YbgF and Com1, may
give a more authentic specificity. Refinement of antigen
combination and the production of fusion molecules com-
prised of the major seroreactive antigens described herein
may lead to improved sensitivity and specificity for the
development of a rapid, accurate, and convenient seoro-
diagnostic test of Q fever.
Conclusions
In summary, the combination of 2D-PAGE, immunoblot
and MALDI-TOF-MS permitted the identification of 20
seroreactive proteins of C. burnetii. A protein microarray
fabricated with recombinant proteins was probed with Q
fever patient sera. Seven proteins (GroEL, YbgF, RplL,
Mip, Com1, OmpH, and Dnak) were recognized as major
seroreactive antigens. The major seroreactive proteins
fabricated in a small array were analyzed with the sera of
patients with Q fever, rickettsial spotted fever, Legionella
pneumonia or streptococcal pneumonia and they gave a
moderate specificity for recognizing of Q fever patient
sera, suggesting these proteins are potential serodiagnos-
tic markers for Q fever.
Methods
Culture and purification of C. burnetii
C. burnetii Xinqiao strain (phase I) was propagated in
embryonated eggs and purified by renografin density cen-
trifugation as previously described [25]. The purified
organisms were suspended in phosphate-buffered saline
buffer (PBS) (8.1 mM Na2HPO4,1 . 9m MN a H 2PO4,
154 mM NaCl, PH7.4) and stored at −70°C.
Mouse and human sera
Thirty two BALB/c mice (male, 6 weeks old) (Laboratory
Animal Center of Beijing, China) were injected intraperi-
toneally with C. burnetii Xinqiao strain (1 × 10
8 cells/
mouse) in a biosafety level 3 laboratory. Eight of the mice
were randomly sacrificed on days 7, 14, 21, and 28 pi.
Ten mg of tissue from the liver, spleen and lungs of each
sacrificed mouse was used to extract DNA with a tissue
DNA extraction kit (Qiagen, GmbH, Germany), respec-
tively. Each DNA sample was eluted from the DNA
extraction column with 200 μl elution buffer according
to the manufacturer’si n s t r u c t i o n .A2μlo ft h eD N A
sample was tested by a real-time quantitative polymerase
chain reaction (qPCR) specific for C. burnetii [26]. The
results of qPCR were expressed as mean ± SD and com-
pared by the repeated measurement data analysis of
variance using SAS 9.1 software (SAS Institute Inc., Cary,
NC). All animal protocols were pre-approved by the Ani-
mal Protection Committee of Laboratory Animal Center
of Beijing and all experiments complied with the current
laws of China.
Fifty six serum samples from Q fever patients were
obtained from the Australian Rickettsial Reference
Laboratory (Geelong, VIC, Australia) and classified into
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ing to the results of the IFA results and clinical details
of the patients. The serum samples from 10 patients
with rickettsial spotted fever and 10 patients with Legio-
nella pneumonia caused by Legionella pneumophila were
also obtained from the Australian Rickettsial Reference
Laboratory. The serum samples of 10 patients diagnosed
with streptococcal pneumonia caused by Streptococcus
pneumoniae and 25 healthy persons were obtained from
the 307 Hospital of PLA (Beijing, China). These serum
samples were all Q fever antibody negative (QAb-negative)
tested as described previously [27]. The present project is
in compliance with the Helsinki Declaration (Ethical Prin-
ciples for Medical Research Involving Human Subjects).
This study was approved by the ethics committee of the
Beijing Institute of Microbiology and Epidemiology. In
each hospital, the serum samples of patients were collected
as part of the routine management of patients without any
additional sampling, and all patient data was deidentified.
Two-dimensional (2-D) electrophoresis of C. burnetii
proteins
The purified C. burnetii organisms were rinsed with cold
PBS and centrifuged at 12,000 g for 30 min at 4°C with an
Allegra™ 21R centrifuge (Beckman, Fullerton, CA). The
supernatant was discarded and the pellet resuspended in
rehydration buffer (7 M urea, 2 M thiourea, 4% [wt/vol]
CHAPS, 1% [wt/vol] DTT, 0.2% [vol/vol] Bio-lyte). The cell
lysates were sonicated (300 W, 3 s on and 9 s off) for
30 min at 4°C using a ultrasonic processor (Sonics & Mate-
rials, Newtown, CT), then centrifuged at 20,000 g for 1 h at
17°C to remove any insoluble material prior to isoelectric
focusing. The supernatant was collected and the proteins
precipitated with a 2-D Clean-Up Kit (Amersham, Piscat-
away, NJ) according to the manufacture’s instruction. The
pellets were resuspended in rehydration buffer and the pro-
tein concentration of the solution determined using the
Bradford method [28]. The protein solution was aliquoted
a n ds t o r e da t−70°C until used.
A3 5 0μl protein solution (800 μg of Coxiella protein)
was loaded onto each 17-cm nonlinear Immobiline Dry-
Strips (pH 3 to 10, Bio-Rad, Hercules, CA). The isoelectric
focusing was performed at 50v for 12 h, 200v for 1 h,
1000v for 1 h, 10, 000v for 11 h, and 500v for 8 h using a
Protean IEF cell system (Bio-Rad, Hercules, CA). Follow-
ing isoelectric focusing, the strips were equilibrated and
placed on sodium dodecyl sulfate (SDS)-polyacrylamide
gels for second-dimension electrophoresis as described
previously [29]. The gels were then stained with modified
Coomassie brilliant blue [30].
Immunoblotting of C. burnetii proteins
Following 2-D electrophoresis, the Coxiella proteins in
the gels were transferred onto a 0.45 μm polyvinylidene
difluoride membranes (Millipore, Bedford, MA) at 0.8
mA/cm
2 f o r1hw i t ht r a n s f e rb u f f e r( 4 8m MT r i s - b a s e ,
39 mM glycine, 0.04% [wt/vol] SDS, 20% [vol/vol]
methanol) and then blocked overnight in blocking buffer
(20 mmol/L Tris-base, 137 mmol/L NaCl supplemented
with 0.05% [vol/vol] Tween 20, 5% [wt/vol] skimmed
milk, pH 7.6) at 4°C. The membranes were then incu-
bated for 1 h with mouse or patient sera diluted 1:500
in blocking buffer. After washing, the membranes were
incubated for 1 h with horseradish peroxidase-conju-
gated goat anti-mouse or goat anti-human IgG (Santa
Cruz Biotechnology, Santa Cruz, CA) diluted 1:10,000 in
blocking buffer [31]. After washing, the reactivity on the
membranes was detected with an ECL Western blot
detection kit (Pierce, Rockford, IL).
To align Coomassie-stained gels with immunoblot
images, gel images were acquired with a GS-800 cali-
brated imaging densitometer( B i o - R a d ,H e r c u l e s ,C A ) .
The spot detection, estimation of isoelectric point (pI)
and molecular weight (Mw) were done by PDQuest 2-D
Analysis Software 8.0.1 (Bio-Rad, Hercules, CA). The
blot images were overlaid onto parallel stained gels to
allow direct comparison of spots from blot images and
stained gels.
Identification of seroreactive proteins
The Coomassie-stained protein spots that correlated with
the seroreactive spots were excised and processed by
Matrix-Assisted Laser Desorption/Ionization Time of
Flight Mass Spectrometry (MALDI-TOF-MS). Protein
digestion and MALDI-TOF-MS were performed by the
National Center of Biomedical Analysis (Beijing, China).
All mass spectra of MALDITOF-MS were obtained on a
Bruker REFLEX III MALDI-TOF-MS (Bruker-Franzen,
Bremen, Germany) as described previously [32]. The resul-
tant peptides were mass fingerprinted and compared
against the National Center for Biotechnology Information
nonredundant databases using the Mascot search engine
(http://www.matrixscience.co.uk). Proteins less than
20 kDa were reconfirmed by an Electrospray Ionization
(ESI)-MS/MS approach and the database search was
finished with a Mascot MS/MS ion search as described
previously [32]. The identification process was repeated at
least three times using appropriate spot candidates from
different gels.
Preparation of recombinant seroreactive proteins
The open reading frames (ORFs) of 20 seroreactive pro-
teins recognized in the immunoproteomic assay were
identified in the genome sequence of C. burnetii RSA 493/
RSA331 (accession number NC_002971/NC_010117) with
the highest sequence coverage and Mascot score. The pri-
mer pairs that amplified the 20 proteins were designed
based on the DNA sequences of the ORFs(Additional file
Xiong et al. BMC Microbiology 2012, 12:35
http://www.biomedcentral.com/1471-2180/12/35
Page 8 of 101: Table S1)and synthesized by the Sangon Company (San-
gon, Shanghai, China). Amplified gene targets were cloned
into pET32a/pQE30, with the resultant recombinant pro-
teins expressed as His (6)-tagged fusion proteins in E. coli
BL21 (DE3)/M15 (Novagen, Madison, WI). The resultant
recombinant proteins were purified by affinity chromato-
graphy with Ni-NTA resin (Qiagen, GmbH, Germany)
and analysed by SDS-PAGE to test their purity and integ-
rity according to the manufacturer’sp r o t o c o l .
Fabrication of the protein microarray
The purified proteins were diluted with elution buffer
(Qiagen, GmbH, Germany) to a final concentration of
200 ~ 300 μg/ml and 15 μl of each protein solution was
transferred to a 384well plate and centrifuged at 300 g
for 5 min in order to remove air bubbles prior to print-
ing. The recombinant proteins were printed onto the
PolymerSlide™ G slides (Captialbio, Beijing, China)
using a SpotBot
® 3 microarrayer (Arrayit corporation,
Sunnyvale, CA). Five replicate spots per protein were
printed, and mouse or human IgG were used as positive
controls [4] and the E. coli cell lysate transformed with
PET-32a plasmids was added as a negative control. The
protein microarrays were incubated in a humid chamber
at 37°C overnight and stored at 4°C. For quality control,
the proteins were incubated with Cy5labeled mouse anti-
body (IgG) to His tag fused with the proteins on the
microarray. Only the proteins with a signal-to-back-
ground ratio of ≥3.0 were used for further analysis [33].
Serological analysis of the protein microarray
The protein microarrays were blocked in blocking buffer
(8.1 mM Na2HPO4, 1.9 mM NaH2PO4,1 5 4m MN a C l ,
1% [wt/vol] BSA, pH 7.4) for 1 h at 37°C. Human sera
(1:100 dilutions) were neutralized overnight in PBS sup-
plemented with the E. coli cell lysate at a final protein con-
centration of 5 mg/ml [21]. Fifty μl of the neutralized
human sera were added to each well of the slides and
incubated for 1 h at 37°C. The slides were washed 5 times
with PBST (8.1 mM Na2HPO4,1 . 9m MN a H 2PO4,
154 mM NaCl, 0.05% [vol/vol] Tween 20), and then incu-
bated with Cy5-conjugated goat anti-mouse or human IgG
(SBA, Gaithersburg, MD) diluted 1:500 in PBST for 1 h at
37°C. Following another 5 washes in PBST, the microarray
was air dried and then scanned for fluorescent signals at a
wavelength of 635 nm using a GenePix Personal 4100A
scanner (Molecular Devices, Sunnyvale, CA).
The scanned images were analyzed by GenePix pro 6.0
software (Molecular Devices, Sunnyvale, CA). The fluor-
escence intensity (FI) of each protein was calculated by
averaging the FIs of 5 replicate spots that were back-
ground subtracted. The normalized data sets were then
analysed by the kruskal-wallis H test using SPSS 16 soft-
ware (IBM, Armonk, New York).
Specificity analysis of the major seroreactive proteins
The major seroreactive proteins identified in the above
serological analysis were used to fabricate a protein micro-
array which was analyzed for its specificity with the sera
from patients with rickettsial spotted fever, Legionella
pneumonia or streptococcal pneumonia. The sera of Q
fever patients and healthy persons were used as positive
and negative controls, respectively. The test and data ana-
lysis method were the same as those mentioned earlier.
Additional material
Additional file 1: Table S1 Primers designed for amplifying the
genes encoding major seroreactive proteins.
Additional file 2: Table S2 The major seroreactive proteins probed
with Q fever patient sera.
Additional file 3: Table S3 Specificity analysis of the major
seroreactive proteins.
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